Comparison of M-Kyoto solution and histidine-tryptophan-ketoglutarate solution with a trypsin inhibitor for pancreas preservation in islet transplantation

Transplantation

Volumn 84, Issue 5, 2007, Pages 655-658

  Noguchi, Hirofumi ^a,b,c,d   Ueda, Michiko ^c   Hayashi, Shuji ^b   Kobayashi, Naoya ^e   Nagata, Hideo ^c   Iwanaga, Yasuhiro ^a   Okitsu, Teru ^a   Matsumoto, Shinichi ^c,d  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c FUJITA HEALTH UNIVERSITY   (Japan)

^d BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^e OKAYAMA UNIVERSITY   (Japan)

Author keywords

Histidine tryptophan ketoglutarate solution; Islet isolation; Islet transplantation; M Kyoto solution; Trypsin inhibitor

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; COLLAGENASE INHIBITOR; HISTIDINE; M KYOTO SOLUTION; OXOGLUTARATE DEHYDROGENASE; PERFLUORO COMPOUND; TRYPSIN INHIBITOR; TRYPTOPHAN; ULINASTATIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENERGY; MOUSE; NONHUMAN; OPERATION DURATION; ORGAN PRESERVATION; ORGAN SIZE; PANCREAS FUNCTION; PANCREAS ISLET; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; PURIFICATION; SKIN FLAP;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; HISTIDINE; ISLETS OF LANGERHANS TRANSPLANTATION; KETOGLUTARIC ACIDS; ORGAN PRESERVATION; PANCREAS; SOLUTIONS; SWINE; TRYPSIN; TRYPSIN INHIBITORS;

EID: 34548736060     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000277625.42147.62     Document Type: Article

References (32)

1. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230.
2. Froud T, Ricordi C, Baidal DA, et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 2005; 5: 2037.
3. Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293: 830.
4. Matsumoto S, Okitsu T, Iwanaga Y, et al. Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet 2005; 365: 1642.
5. Noguchi H, Iwanaga Y, Okitsu T, et al. Evaluation of islet transplantation from non-heart beating donors. Am J Transplant 2006; 6: 2476.
6. Matsumoto S, Okitsu T, Iwanaga Y, et al. Successful islet transplantation from nonheartbeating donor pancreata using modified Ricordi islet isolation method. Transplantation 2006; 82: 460.
7. Matsumoto S, Kuroda Y. Perfluorocarbon for organ preservation before transplantation. Transplantation 2002; 74: 1804.
8. Matsumoto S, Qualley SA, Goel S, et al. Effect of the two-layer (University of Wisconsin solution-perfluorochemical plus O2) method of pancreas preservation on human islet isolation, as assessed by the Edmonton Isolation Protocol. Transplantation 2002; 74: 1414.
9. Fujimoto S, Mukai E, Hamamoto Y, et al. Prior exposure to high glucose augments depolarization-induced insulin release by mitigating the decline of ATP level in rat islets. Endocrinology 2002; 143: 213.
10. Robertson GS, Chadwick D, Thirdborough S, et al. Human islet isolation - a prospective randomized comparison of pancreatic vascular perfusion with hyperosmolar citrate or University of Wisconsin solution. Transplantation 1993; 56: 550.
11. Contractor HH, Johnson PR, Chadwick DR, et al. The effect of UW solution and its components on the collagenase digestion of human and porcine pancreas. Cell Transplant 1995; 4: 615.
12. Noguchi H, Ueda M, Nakai Y, et al. Modified two-layer preservation method (M-Kyoto/PFC) improves islet yields in islet isolation. Am J Transplant 2006; 6: 496.
13. Omasa M, Hasegawa S, Bando T, et al. Application of ET-Kyoto solution in clinical lung transplantation. Ann Thorac Surg 2004; 77: 338.
14. Chen F, Fukuse T, Hasegawa S, et al. Effective application of ET-Kyoto solution for clinical lung transplantation. Transplant Proc 2004; 36: 2812.
15. Wu SF, Suzuki Y, Kitahara AK, et al. Skin flap storage with intracellular and extracellular solutions containing trehalose. Ann Plast Surg 1999; 43: 289.
16. Belzer FO, Southard JH. Organ preservation and transplantation. Prog Clin Biol Res 1986; 224: 291.
17. Bretschneider HJ. Myocardial protection. Thorac Cardiovasc Surg 1980; 28: 295.
18. Erhard J, Lange R, Scherer R, et al. Comparison of histidine - tryptophan - ketoglutarate (HTK) solution versus University of Wisconsin (UW) solution for organ preservation in human liver transplantation. A prospective, randomized study. Transpl Int 1994;7: 177.
19. Hesse UJ, Troisi R, Jacobs B, et al. Cold preservation of the porcine pancreas with histidine - tryptophan - ketoglutarate solution. Transplantation 1998; 66: 1137.
20. Troisi R, Meester D, Van Den Broecke C, et al. Functional and structural integrity of porcine pancreatic grafts subjected to a period of warm ischemia and cold preservation with histidine - tryptophan - ketoglutarate (custodiol) or University of Wisconsin solution. Transplantation. 2003; 75: 1793.
21. Leonhardt U, Tytko A, Exner B, et al. The effect of different solutions for organ preservation on immediate postischemic pancreatic function in vitro. Transplantation 1993; 55: 11.
22. Potdar S, Malek S, Eghtesad B, et al. Initial experience using histidine - tryptophan - ketoglutarate solution in clinical pancreas transplantation. Clin Transplant 2004; 18: 661.
23. Englesbe MJ, Moyer A, Kim DY, et al. Early pancreas transplant outcomes with histidine - tryptophan - ketoglutarate preservation: A multicenter study. Transplantation 2006; 82: 136.
24. Fridell JA, Agarwal A, Milgrom ML, et al. Comparison of histidine - tryptophan - ketoglutarate solution and University of Wisconsin solution for organ preservation in clinical pancreas transplantation. Transplantation 2004; 77: 1304.
25. Goto M, Holgersson J, Kumagai-Braesch M, Korsgren O. The ADP/ATP ratio: A novel predictive assay for quality assessment of isolated pancreatic islets. Am J Transplant 2006; 6: 2483.
26. Noguchi H, Matsushita M, Okitsu T, et al. A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nat Med 2004; 10: 305.
27. Noguchi H, Nakai Y, Matsumoto S, et al. Cell permeable peptide of JNK inhibitor prevents islet apoptosis immediately after isolation and improves islet graft function. Am J Transplant 2005; 5: 1848.
28. Noguchi H, Nakai Y, Ueda M, et al. Activation of c-Jun NH(2)-terminal kinase (JNK) pathway during islet transplantation and prevention of islet graft loss by intraportal injection of JNK inhibitor. Diabetologia 2007; 50: 612.
29. Chadwick DR, Robertson GS, Contractor HH, et al. Storage of pancreatic digest before islet purification. The influence of colloids and the sodium to potassium ratio in University of Wisconsin-based preservation solutions. Transplantation 1994; 58: 99.
30. Matsumoto S, Fujino Y, Suzuki Y, et al. Evidence of protein synthesis during resuscitation of ischemically damaged canine pancreas by the two-layer method. Pancreas 2000; 20: 411.
31. Tanioka Y, Kuroda Y, Kim Y, et al. The effect of ouabain (inhibitor of an ATP-dependent Na+/K+ pump) on the pancreas graft during preservation by the two-layer method. Transplantation 1996; 62: 1730.
32. Morita A, Kuroda Y, Saitoh Y. Evaluation of the viability and energy metabolism of ischemically damaged canine pancreas during preservation by the two-layer (University of Wisconsin solution/perfluorochemical) cold storage method. Kobe J Med Sci 1992;38: 205.